Genetics and Biomarkers of Human Ageing

Dr. Joris Deelen

Max Planck Institute for Biology of Ageing

Website Publications

Why do some people age more healthily than others?

This is the main question we try to address in our research group. To this end, we are studying the genetic mechanisms underlying healthy ageing in humans. We mainly do this by investigating the effect of genetic variants that are unique to long-lived individuals on the functioning of pathways implicated in ageing and/or age-related diseases. Moreover, we try to identify and validate biomarkers of healthy ageing using data from large-scale international collaborations of human studies.

Our research is focused on two main aims:

  1. Functional characterization of rare protein-altering genetic variants involved in healthy ageing (currently our primary research line)
  2. Establish human ageing studies in Cologne to determine the efficacy of previously identified biomarkers of healthy ageing in clinical studies. To address these aims, our lab uses cellular models (including mouse embryonic stem cells) and mice, as well as samples from older-aged human (≥70 years of age).

Tags:  Embryonal Stem Cells  Bioinformatics  Aging  Genome Editing  Translational Research  Biomarker